TREATMENTS &
RESEARCH
latest
treatment
information
here.
Dr. Huntley's
Diagnosis
Checklist
See what questions
a doctor would ask.
Zidovudine (medical condition): Some evidence indicates that exposure to Zidovudine (an anti-HIV drug) has a possible link to an increased risk of developing cancer in humans. The carcinogenicity of the substance may be influenced by the duration and level of exposure.
See also:
Possible human carcinogenic exposure - Zidovudine:
»Introduction: Possible human carcinogenic exposure - Zidovudine
»Symptoms of Possible human carcinogenic exposure - Zidovudine
Zidovudine: A thymidine analog that is an inhibitor of in vitro replication of HIV virus, the causative agent of AIDS and ARC, and is used in the management of these diseases. SYN: azidothymidine.
Source: Stedman's Medical Spellchecker, © 2006 Lippincott Williams & Wilkins. All rights reserved.
Zidovudine: an antiviral drug (trade name Retrovir) used in the treatment of AIDS; adverse side effects include liver damage and suppression of the bone marrow.
Source: WordNet 2.1
Zidovudine: A synthetic dideoxynucleoside. After intracellular phosphorylation to its active metabolite, zidovudine inhibits DNA polymerase, resulting in the inhibition of DNA replication and cell death. This agent also decreases levels of available pyrimidines. (NCI04)
Source: Diseases Database
Zidovudine: synthetic thymidine analog that inhibits replication of some retroviruses, including human immunodeficiency virus; used in the management of AIDS or HIV infection.
Source: CRISP
Zidovudine: A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia.
Source: MeSH 2007
Zidovudine: Another name for Possible human carcinogenic exposure - Zidovudine (or close medical condition association).
»Introduction: Possible human carcinogenic exposure - Zidovudine
»Symptoms of Possible human carcinogenic exposure - Zidovudine
Some of the symptoms of Zidovudine incude:
Read more about symptoms of Zidovudine (Possible human carcinogenic exposure - Zidovudine)
Source: Diseases Database
Source - WordNet 2.1
Source - MeSH 2007
Source - MeSH 2007
Source - CRISP
Source - WordNet 2.1
Source: CRISP
Source: CRISP
The following list attempts to classify Zidovudine into categories where each line is subset of the next.
Source: WordNet 2.1
Source: Diseases Database
Search to find out more about Zidovudine:
|
What do you think about the features of this website? Take our user survey and have your say:
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.